NextCure, Inc. ( NXTC) - Stock Earnings
NXTC Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -8.6 million USD | — USD |
| 2025Q4 | -9.4 million USD | — USD |
| 2026Q1 | -9.8 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
NXTC Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -62.7 million USD | — USD |
| 2024 | -55.7 million USD | — USD |
| 2025 | -55.8 million USD | — USD |
| 2026 Est. | — | — |
NXTC
Price: $2.02
52 week price:
Earnings Per Share: -16.82 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 224200
Market Capitalization: 8.4 million